Gayong Shim Selected Research

Gayong Shim Research Topics

Disease

41	Neoplasms (Cancer) 03/2024 - 09/2009
2	Lymphatic Metastasis 01/2024 - 02/2023
2	Melanoma (Melanoma, Malignant) 10/2021 - 12/2012
2	Lung Neoplasms (Lung Cancer) 01/2019 - 04/2013
1	Communicable Diseases (Infectious Diseases) 06/2023
1	Neoplasm Metastasis (Metastasis) 02/2023
1	Fibrosis (Cirrhosis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 06/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Diabetes Mellitus 01/2017
1	Fatty Liver 01/2017
1	Obesity 01/2017
1	Arthritis (Polyarthritis) 05/2015
1	Carcinoma (Carcinomatosis) 08/2014
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2013
1	Lewis Lung Carcinoma 04/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2010
6	Liposomes (Liposome)IBA 01/2022 - 12/2009
6	Small Interfering RNA (siRNA)IBA 04/2013 - 09/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 09/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 06/2017
4	Photosensitizing Agents (Photosensitizers)IBA 11/2020 - 09/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2020
3	Peptides (Polypeptides)IBA 01/2022 - 09/2015
3	CalreticulinIBA 11/2021 - 02/2020
3	graphene oxideIBA 09/2014 - 04/2013
3	LipofectamineIBA 12/2011 - 12/2009
2	Contrast MediaIBA 09/2023 - 02/2023
2	HydrogelsIBA 01/2023 - 10/2021
2	GoldIBA 10/2022 - 11/2020
2	HomoharringtonineIBA 10/2022 - 08/2014
2	AntibodiesIBA 11/2020 - 01/2019
2	Cancer VaccinesIBA 12/2019 - 01/2019
2	Hyaluronic Acid (Hyaluronan)IBA 09/2015 - 12/2013
2	Taurocholic Acid (Sodium Taurocholate)IBA 09/2014 - 06/2012
2	Antineoplastic Agents (Antineoplastics)IBA 12/2013 - 04/2013
1	Indicators and Reagents (Reagents)IBA 01/2024
1	EnzymesIBA 09/2023
1	Chelating AgentsIBA 09/2023
1	GadoliniumIBA 09/2023
1	MetalsIBA 09/2023
1	VaccinesIBA 06/2023
1	AntigensIBA 01/2023
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023
1	CollagenIBA 01/2023
1	promelittinIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 10/2021
1	Melanins (Melanin)IBA 10/2021
1	microplasminIBA 10/2021
1	liposomal doxorubicin (Doxil)FDA Link 10/2021
1	FibrinIBA 10/2021
1	6-bromo-2-naphthyl sulfate (BNS)IBA 11/2020
1	Tannic Acid FDA Link 11/2020
1	chlorinIBA 02/2020
1	Nucleotide AptamersIBA 01/2020
1	polydopamineIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 12/2019
1	Nucleic AcidsIBA 12/2019
1	OvalbuminIBA 12/2019
1	ChitosanIBA 12/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2019
1	atezolizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Amyloid beta-PeptidesIBA 01/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	ClaudinsIBA 06/2017
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 06/2017
1	AMP-Activated Protein KinasesIBA 01/2017
1	BerberineIBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	LipidsIBA 01/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2014
1	Messenger RNA (mRNA)IBA 04/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2013
1	edelfosineIBA 12/2012
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2012
1	LigandsIBA 12/2012
1	tetraiodothyroacetic acid (TA(4))IBA 12/2012
1	IntegrinsIBA 12/2012
1	LysophospholipidsIBA 12/2012
1	Histone Deacetylase InhibitorsIBA 06/2012
1	Heparin (Liquaemin)FDA LinkGeneric 06/2012
1	Vorinostat FDA Link 06/2012
1	mirdametinibIBA 12/2011

Therapy/Procedure

10	Therapeutics 03/2024 - 09/2011
9	Intravenous Administration 10/2022 - 09/2011
5	Immunotherapy 03/2024 - 12/2019
3	Phototherapy (Light Therapy) 11/2021 - 06/2017
3	Lasers (Laser) 11/2020 - 04/2014
3	Drug Therapy (Chemotherapy) 01/2020 - 09/2011
2	Intravenous Injections 11/2020 - 02/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024
1	Lymph Node Excision (Lymph Node Dissection) 01/2024
1	Aftercare (After-Treatment) 11/2020
1	Subcutaneous Injections 12/2019
1	Withholding Treatment 08/2014